C Delgado1, A Araneda2, M I Behrens3. 1. Departamento de Neurología y Neurocirugía, Hospital Clínico, Universidad de Chile, Santiago, Chile. 2. Escuela de Posgrado, Facultad de Medicina, Universidad de Chile, Santiago, Chile. 3. Departamento de Neurología y Neurocirugía, Hospital Clínico, Universidad de Chile, Santiago, Chile; Instituto de Ciencias Biomédicas, Programa de Farmacología, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Centro de Investigación Clínica Avanzada (CICA), Facultad de Medicina, Hospital Clínico Universidad de Chile, Santiago, Chile; Clínica Alemana de Santiago, Santiago, Chile. Electronic address: behrensl@uchile.cl.
Abstract
INTRODUCTION: Few studies have validated the Spanish-language version of the Montreal Cognitive Assessment (MoCA-S) test in Latin American populations. OBJETIVE: To evaluate the psychometric properties and discriminant validity of the MoCA-S in elderly patients in Santiago de Chile. METHODS: 172 individuals were grouped according to their clinical diagnosis based on the Clinical Dementia Rating (CDR) scale as follows: amnestic mild cognitive impairment (aMCI; n±24), non-amnestic MCI (naMCI; n±24), mild dementia (n±20), and cognitively normal (n±104). Participants were evaluated with both the MoCA-S and the Mini-Mental State Examination (MMSE) to determine the discriminant validity of the MoCA-S. RESULTS: Mean age and years of schooling were 73±6 and 11±4 years, respectively, with no significant intergroup differences. The MoCA-S displayed good internal consistency (Cronbach's α: 0.772), high inter-rater reliability (Spearman correlation coefficient: 0.846; P<.01), and high intra-rater reliability (test-retest reliability coefficient: 0.922; P<.001). The MoCA-S was found to be an effective and valid test for detecting aMCI (AUC±0.903) and mild dementia (AUC±0.957); its effectiveness for detecting naMCI was lower (AUC±0.629). The optimal cut-off points for aMCI and mild dementia were<21 and<20, respectively, with sensitivity and specificity rates of 75% and 82% for aMCI and 90% and 86% for mild dementia. The level of education had a great impact on scores: as a result, 2 points were added for patients with less than 8 years of schooling and one point for patients with 8-12 years of schooling (MoCA-S1-2). The MoCA-S1-2 showed significantly greater discriminant validity than the MMSE for differentiating aMCI from dementia. CONCLUSIONS: The MoCA-S1-2 is a short, easy-to-use, and useful test for diagnosing aMCI and mild dementia.
INTRODUCTION: Few studies have validated the Spanish-language version of the Montreal Cognitive Assessment (MoCA-S) test in Latin American populations. OBJETIVE: To evaluate the psychometric properties and discriminant validity of the MoCA-S in elderly patients in Santiago de Chile. METHODS: 172 individuals were grouped according to their clinical diagnosis based on the Clinical Dementia Rating (CDR) scale as follows: amnestic mild cognitive impairment (aMCI; n±24), non-amnestic MCI (naMCI; n±24), mild dementia (n±20), and cognitively normal (n±104). Participants were evaluated with both the MoCA-S and the Mini-Mental State Examination (MMSE) to determine the discriminant validity of the MoCA-S. RESULTS: Mean age and years of schooling were 73±6 and 11±4 years, respectively, with no significant intergroup differences. The MoCA-S displayed good internal consistency (Cronbach's α: 0.772), high inter-rater reliability (Spearman correlation coefficient: 0.846; P<.01), and high intra-rater reliability (test-retest reliability coefficient: 0.922; P<.001). The MoCA-S was found to be an effective and valid test for detecting aMCI (AUC±0.903) and mild dementia (AUC±0.957); its effectiveness for detecting naMCI was lower (AUC±0.629). The optimal cut-off points for aMCI and mild dementia were<21 and<20, respectively, with sensitivity and specificity rates of 75% and 82% for aMCI and 90% and 86% for mild dementia. The level of education had a great impact on scores: as a result, 2 points were added for patients with less than 8 years of schooling and one point for patients with 8-12 years of schooling (MoCA-S1-2). The MoCA-S1-2 showed significantly greater discriminant validity than the MMSE for differentiating aMCI from dementia. CONCLUSIONS: The MoCA-S1-2 is a short, easy-to-use, and useful test for diagnosing aMCI and mild dementia.
Authors: Sebastian Bello-Lepe; María Francisca Alonso-Sánchez; Alonso Ortega; Marcelo Gaete; Marcela Veliz; Juan Lira; Claudia Paz Perez Salas Journal: Dement Geriatr Cogn Dis Extra Date: 2020-10-14
Authors: Tiago C C Pinto; Marília S P Santos; Leonardo Machado; Tatiana M Bulgacov; Antônio L Rodrigues-Junior; Gabriela A Silva; Maria Lúcia G Costa; Rosana C C Ximenes; Everton B Sougey Journal: Dement Geriatr Cogn Dis Extra Date: 2019-02-07
Authors: José Manuel Santacruz Escudero; Jonathan Beltrán; Álvaro Palacios; Claudia Marcela Chimbí; Diana Matallana; Pablo Reyes; Victor Perez-Sola; Hernando Santamaría-García Journal: Front Aging Neurosci Date: 2019-07-24 Impact factor: 5.750
Authors: Ana M Rodríguez-Salgado; Jorge J Llibre-Guerra; Elena Tsoy; Ana Ibis Peñalver-Guia; Giosmany Bringas; Sabrina J Erlhoff; Joel H Kramer; Isabel Elaine Allen; Victor Valcour; Bruce L Miller; Juan J Llibre-Rodríguez; Katherine L Possin Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Felipe Salech; Daniela P Ponce; Carol D SanMartín; Nicole K Rogers; Carlos Chacón; Mauricio Henríquez; Maria I Behrens Journal: Front Aging Neurosci Date: 2017-10-05 Impact factor: 5.750
Authors: Felipe Salech; Daniela P Ponce; Carol D SanMartín; Nicole K Rogers; Mauricio Henríquez; Maria I Behrens Journal: Front Neurosci Date: 2018-02-08 Impact factor: 4.677